About Denosumab
            
            Class: | Monoclonal antibody (RANKL inhibitor)  
Use: | Treatment of osteoporosis in postmenopausal women and men at high risk for fracture; treatment of bone loss associated with hormone ablation in patients with prostate or breast cancer; treatment of giant cell tumor of bone.  
Adult dose: | 60 mg subcutaneously once every 6 months.  
Pediatric dose: | Not established; not indicated for use in pediatric patients.  
Side effects: | Back pain, pain in extremity, hypercholesterolemia, musculoske
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (RANKL inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of osteoporosis in postmenopausal women and men at high risk for fracture; treatment of bone loss associated with hormone ablation in patients with prostate or breast cancer; treatment of giant cell tumor of bone.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze. Allow to reach room temperature before administration (do not exceed 30°C/86°F).
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Amgen Europe B.V., NETHERLANDS
                    
                    
                    Package Size
                    1ml Pre-filled Syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1180.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        60 mg subcutaneously once every 6 months.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; not indicated for use in pediatric patients.
                    
                 
                
                
                    
                        Side Effects
                    
                    Back pain, pain in extremity, hypercholesterolemia, musculoskeletal pain, hypocalcemia, and skin infections.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypocalcemia; hypersensitivity to denosumab or any component of the formulation; pregnancy (Category X).
         
        
        
            
                Important Warnings
            
            Risk of serious infections, including skin infections; osteonecrosis of the jaw; atypical femoral fractures; hypocalcemia; and potential for severe allergic reactions.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.